Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer

NCT04884906 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Cervical Cancer

Interventions

BIOLOGICAL: Camrelizumab
RADIATION: radiotherapy
DRUG: Albumin Paclitaxel
DRUG: Cisplatin

Sponsor

Tianjin Medical University Cancer Institute and Hospital